OTC Picks

[Let's Roll]

$BKLLF / $CODE Adding to the previously announced provisional patent filing for a transdermal patch delivery of hydroxychloroquine, the private company with which Codebase has entered into an arms-length agreement to acquire a 49% interest, Glanis Pharmaceuticals Inc, has filed for an additional US provisional patent for the novel oral drug delivery of hydroxychloroquine (HCQ) and chloroquine (CQ).

"With the previously announced transdermal patch filing, and now this novel oral delivery filing, steps are advancing quickly to satisfy a need for an improved drug delivery system of CQ and HCQ, which can replace the multiple dosage regimen associated with oral tablets and also decrease the probabilities of getting side effects related to GI tract disturbance," said Codebase President and CEO, Mr. George Tsafalas.

https://www.bloomberg.com/press-releases/2020-04-23/codebase-investment-adds-oral-mucosal-patent-filing-expanding-transdermal-treatments